GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (HAM:LL3) » Definitions » Net Current Asset Value

PanGenomic Health (HAM:LL3) Net Current Asset Value : €-0.17 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PanGenomic Health Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

PanGenomic Health's net current asset value per share for the quarter that ended in Sep. 2024 was €-0.17.

The historical rank and industry rank for PanGenomic Health's Net Current Asset Value or its related term are showing as below:

During the past 3 years, the highest Price-to-Net-Current-Asset-Value Ratio of PanGenomic Health was 66.67. The lowest was 66.67. And the median was 66.67.

HAM:LL3's Price-to-Net-Current-Asset-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.5
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

PanGenomic Health Net Current Asset Value Historical Data

The historical data trend for PanGenomic Health's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Net Current Asset Value Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22 Dec23
Net Current Asset Value
0.74 -0.09 -0.70

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.70 -0.75 -0.16 -0.17

Competitive Comparison of PanGenomic Health's Net Current Asset Value

For the Health Information Services subindustry, PanGenomic Health's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PanGenomic Health's Price-to-Net-Current-Asset-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's Price-to-Net-Current-Asset-Value falls into.



PanGenomic Health Net Current Asset Value Calculation

PanGenomic Health's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.042-1.515-0-0)/2.09935
=-0.70

PanGenomic Health's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2024 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.041-1.136-0-0)/6.39981
=-0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health  (HAM:LL3) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


PanGenomic Health Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health Business Description

Comparable Companies
Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

PanGenomic Health Headlines

No Headlines